PDF herunterladen
Planta Med 2010; 76(14): 1570-1575
DOI: 10.1055/s-0030-1249778
Pharmacology
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Constituents of Cinnamon Inhibit Bacterial Acetyl CoA Carboxylase

Glen Meades1  Jr. , Rachel L. Henken2 , Grover L. Waldrop1 , Md. Mukhlesur Rahman3 , S. Douglass Gilman2 , Guy P. P. Kamatou4 , Alvaro M. Viljoen4 , Simon Gibbons3
  • 1Division of Biochemistry and Molecular Biology, Louisiana State University, Baton Rouge, Louisiana, USA
  • 2Department of Chemistry, Louisiana State University, Baton Rouge, Louisiana, USA
  • 3Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, London, UK
  • 4Department of Pharmaceutical Sciences, Faculty of Science, Tshwane University of Technology, Pretoria, South Africa
Weitere Informationen

Publikationsverlauf

received Dec. 7, 2009 revised February 22, 2010

accepted March 4, 2010

Publikationsdatum:
08. April 2010 (online)

    Lizenzen und Reprints

Abstract

Cinnamon bark (Cinnamomum zeylanicum) is used extensively as an antimicrobial material and currently is being increasingly used in Europe by people with type II diabetes to control their glucose levels. In this paper we describe the action of cinnamon oil, its major component, trans-cinnamaldehyde, and an analogue, 4-hydroxy-3-methoxy-trans-cinnamaldehyde against bacterial acetyl-CoA carboxylase in an attempt to elucidate the mechanism of action of this well-known antimicrobial material. These natural products inhibited the carboxyltransferase component of Escherichia coli acetyl-CoA carboxylase but had no effect on the activity of the biotin carboxylase component. The inhibition patterns indicated that these products bound to the biotin binding site of carboxyltransferase with trans-cinnamaldehyde having a Ki value of 3.8 ± 0.6 mM. The inhibition of carboxyltransferase by 4-hydroxy-3-methoxy-trans-cinnamaldehyde was analyzed with a new assay for this enzyme based on capillary electrophoresis. These results explain, in part, the antibacterial activity of this well-known antimicrobial material.

Key words

Cinnamomum zeylanicum - Lauraceae - trans‐cinnamaldehyde - acetyl‐CoA carboxylase - carboxyltransferase

References

  • 1 The King James Bible, Exodus, 30: 23 – 26. 
    Google Scholar
  • 2 Farrell K T. Spices, condiments and seasonings. New York; The AVI Publisher Co. 1985
    PubMedGoogle Scholar
  • 3 Mishra A, Bhatti R, Singh A, Ishar M P S. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy.  Planta Med. 2010;  76 412-417
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 4 de Luis D A, Aller R, Romero E. Cinnamon as possible treatment of diabetes mellitus type 2.  Med Clin (Barc). 2008;  131 279
    PubMedGoogle Scholar
  • 5 Ammon H P. Cinnamon in type 2 diabetics.  Med Monatsschr Pharm. 2008;  31 179-183
    PubMedGoogle Scholar
  • 6 Baker W L, Gutierrez-Williams G, White C M, Kluger J, Coleman C I. Effect of cinnamon on glucose control and lipid parameters.  Diabetes Care. 2008;  31 41-43
    CrossrefPubMedGoogle Scholar
  • 7 Dugoua J J, Seely D, Perri D, Cooley K, Forelli T, Mills E, Koren G. From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark.  Can J Physiol Pharmacol. 2007;  85 837-847
    CrossrefPubMedGoogle Scholar
  • 8 Suppapitiporn S, Kanpaksi N, Suppapitiporn S. The effect of cinnamon cassia powder in type 2 diabetes mellitus.  J Med Assoc Thai. 2006;  89 (Suppl. 3) S200-S205
    PubMedGoogle Scholar
  • 9 Inouye S, Uchida K, Nishiyama Y, Hasumi Y, Yamaguchi H, Abe S. Combined effect of heat, essential oils and salt on fungicidal activity against Trichophyton mentagrophytes in a foot bath.  Nippon Ishinkin Gakkai Zasshi. 2007;  48 27-36
    CrossrefPubMedGoogle Scholar
  • 10 Pozzatti P, Scheid L A, Spader T B, Atayde M L, Santurio J M, Alves S H. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.  Can J Microbiol. 2008;  54 950-956
    CrossrefPubMedGoogle Scholar
  • 11 Prabuseenivasan S, Jayakumar M, Ignacimuthu S. In vitro antibacterial activity of some plant essential oils.  BMC Complement Altern Med. 2006;  6 39
    CrossrefPubMedGoogle Scholar
  • 12 Shahverdi A R, Monsef-Esfahani H R, Tavasoli F, Zaheri A, Mirjani R. trans-Cinnamaldehyde from Cinnamomum zeylanicum bark essential oil reduces the clindamycin resistance of Clostridium difficile in vitro.  J Food Sci. 2007;  72 S055-S058
    CrossrefPubMedGoogle Scholar
  • 13 Wong S Y, Grant I R, Friedman M, Elliott C T, Situ C. Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis.  Appl Environ Microbiol. 2008;  74 5986-5990
    CrossrefPubMedGoogle Scholar
  • 14 Mosqueda-Melgar J, Raybaudi-Massilia R M, Martín-Belloso O. Combination of high-intensity pulsed electric fields with natural antimicrobials to inactivate pathogenic microorganisms and extend the shelf-life of melon and watermelon juices.  Food Microbiol. 2008;  25 479-491
    CrossrefPubMedGoogle Scholar
  • 15 Marongiu B, Piras A, Porcedda S, Tuveri E, Sanjust E, Meli M, Sollai F, Zucca P, Rescigno A. Supercritical CO2 extract of Cinnamomum zeylanicum: chemical characterization and antityrosinase activity.  J Agric Food Chem. 2007;  55 10022-10027
    CrossrefPubMedGoogle Scholar
  • 16 Kim D H, Kim C H, Kim M S, Kim J Y, Jung K J, Chung J H, An W G, Lee J W, Yu B P, Chung H Y. Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde.  Biogerontology. 2007;  8 545-554
    CrossrefPubMedGoogle Scholar
  • 17 McCarty M F. Toward prevention of Alzheimers disease – potential nutraceutical strategies for suppressing the production of amyloid beta peptides.  Med Hypotheses. 2006;  67 682-697
    CrossrefPubMedGoogle Scholar
  • 18 Kannappan S, Jayaraman T, Rajasekar P, Ravichandran M K, Anuradha C V. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat.  Singapore Med J. 2006;  47 858-863
    PubMedGoogle Scholar
  • 19 O'Keefe J H, Gheewala N M, O'Keefe J O. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health.  J Am Coll Cardiol. 2008;  51 249-255
    CrossrefPubMedGoogle Scholar
  • 20 Qin B, Polansky M M, Sato Y, Adeli K, Anderson R A. Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals.  J Nutr Biochem. 2009;  20 901-908
    CrossrefPubMedGoogle Scholar
  • 21 Gibbons S, Udo E E. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant.  Phytother Res. 2000;  14 139-140
    CrossrefPubMedGoogle Scholar
  • 22 Ross J I, Farrell A M, Eady E A, Cove J H, Cunliffe W J. Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis.  J Antimicrob Chemother. 1989;  24 851-862
    CrossrefPubMedGoogle Scholar
  • 23 Richardson J F, Reith S. Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods.  J Hosp Infect. 1993;  25 45-52
    CrossrefPubMedGoogle Scholar
  • 24 Kaatz G W, Seo S M, Ruble C A. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.  Antimicrob Agents Chemother. 1993;  37 1086-1094
    CrossrefPubMedGoogle Scholar
  • 25 Blanchard C Z, Lee Y M, Frantom P A, Waldrop G L. Mutations at four active site residues of biotin carboxylase abolish substrate-induced synergism by biotin.  Biochemistry. 1999;  38 3393-3400
    CrossrefPubMedGoogle Scholar
  • 26 Blanchard C Z, Waldrop G L. Overexpression and kinetic characterization of the carboxyltransferase component of acetyl-CoA carboxylase.  J Biol Chem. 1998;  273 19140-19145
    CrossrefPubMedGoogle Scholar
  • 27 Cleland W W. Statistical analysis of enzyme kinetic data.  Methods Enzymol. 1979;  63 103-138
    PubMedGoogle Scholar
  • 28 Cronan J E, Waldrop G L. Multi-subunit acetyl-CoA carboxylases.  Prog Lipid Res. 2002;  41 407-435
    CrossrefPubMedGoogle Scholar
  • 29 Levert K L, Waldrop G L. A bisubstrate analog inhibitor of the carboxyltransferase component of acetyl-CoA carboxylase.  Biochem Biophys Res Commun. 2002;  291 1213-1217
    CrossrefPubMedGoogle Scholar
  • 30 Glatz Z. Determination of enzymatic activity by capillary electrophoresis.  J Chromatogr B. 2006;  841 23-37
    CrossrefPubMedGoogle Scholar
  • 31 Chantiwas R, Yan X, Gilman S D. Biological applications of microfluidics. Hoboken; John Wiley & Sons 2008: 135-170
    PubMedGoogle Scholar
  • 32 Holden H M, Benning M M, Haller T, Gerlt J A. The crotonase superfamily: divergently related enzymes that catalyze different reactions involving acyl coenzyme A thioesters.  Acc Chem Res. 2001;  34 145-157
    CrossrefPubMedGoogle Scholar
  • 33 Hamed R B, Batchelar E T, Clifton I J, Schofield C J. Mechanisms and structures of crotonase superfamily enzymes – how nature controls enolate and oxyanion reactivity.  Cell Mol Life Sci. 2008;  65 2507-2527
    CrossrefPubMedGoogle Scholar
  • 34 Bilder P, Lightle S, Bainbridge G, Ohren J, Finzel B, Sun F, Holley S, Al-Kassim L, Spessard C, Melnick M, Newcomer M, Waldrop G L. The structure of the carboxyltransferase component of acetyl-CoA carboxylase reveals a zinc-binding motif unique to the bacterial enzyme.  Biochemistry. 2006;  45 1712-1722
    CrossrefPubMedGoogle Scholar
  • 35 Leonard P M, Brzozowski A M, Lebedev A, Marshall C M, Smith D J, Verma C S, Walton N J, Grogan G. The 1.8 Å resolution structure of hydroxycinnamoyl-coenzyme A hydratase-lyase (HCHL) from Pseudomonas fluorescens, an enzyme that catalyses the transformation of feruloyl-coenzyme A to vanillin.  Acta Crystalllogr D. 2006;  D62 1494-1501
    PubMedGoogle Scholar
  • 36 Bahnson B J, Anderson V E, Petsko G A. Structural mechanism of enoyl-CoA hydratase: Three atoms from single water are added in either an E1cb stepwise or concerted fashion.  Biochemistry. 2002;  41 2621-2629
    CrossrefPubMedGoogle Scholar
  • 37 Miller J R, Dunham S, Mochalkin I, Banotai C, Bowman M, Buist S, Dunkle B, Hanna D, Harwood H J, Huband M D, Karnovsky A, Kuhn M, Limberakis C, Liu J Y, Mehrens S, Mueller W T, Narasimhan L, Ogden A, Ohren J, Prasad J V N V, Shelly J A, Skerlos L, Sulavik M, Thomas V H, VanderRoest S, Wang L, Wang Z, Whitton A, Zhu T, Stover C K. A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore.  PNAS. 2009;  106 1737-1742
    CrossrefPubMedGoogle Scholar
  • 38 Freiberg C, Brunner N A, Schiffer G, Lampe T, Pohlmann J, Brands M, Raabe M, Häbich D, Ziegelbauer K J. Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity.  J Biol Chem. 2004;  279 26066-26073
    CrossrefPubMedGoogle Scholar
  • 39 Congreve M, Chessari G, Tisi D, Woodhead A J. Recent developments in fragment-based drug discovery.  J Med Chem. 2008;  51 3661-3680
    CrossrefPubMedGoogle Scholar

Simon Gibbons

Department of Pharmaceutical and Biological Chemistry
The School of Pharmacy
University of London

29–39 Brunswick Square

London WC1N 1AX

United Kingdom

Telefon: + 44 20 77 53 59 13

eMail: simon.gibbons@pharmacy.ac.uk

      >